PPARG and non-alcoholic fatty liver: Furthermore, supplementation with FOSs alone may have an impact on hepatic pparγ expression through the stimulation of the intestinal bacteria to produce short-chain fatty acids, which can act as ligands for this receptor and mitigate disorders related to NAFL [30].